Equity Capital Markets

Company · CIK 1783328

TScan Therapeutics, Inc.

CIK1783328 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inDE
Business addressMA
ListedTCRX (Nasdaq)
First annual or quarterly report2021-08-19

Offerings

5 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-285570
ShelfEffective
 2025-03-052025-03-142
333-268260
ShelfEffective
 2022-11-092024-12-266
333-277699
ShelfEffective
 2024-03-062024-04-184
333-268261
ShelfEffective
 2022-11-092023-05-162
333-255491
IPOFinal prospectus
 2021-04-232021-07-197

Filings

22
FiledFilingRegistrationAccession
2025-03-14EFFECTDeclared effective 333-2855709999999995-25-000693
2025-03-05S-3Shelf registered 333-2855700001193125-25-047159
2024-12-26424B5Shelf takedown 333-2682600001193125-24-284669
2024-04-18424B5Shelf takedown 333-2776990001193125-24-099491
2024-04-16424B5Shelf takedown 333-2776990001193125-24-097937
2024-04-12EFFECTDeclared effective 333-2776999999999995-24-000956
2024-03-06S-3Shelf registered 333-2776990001193125-24-060718
2023-05-30424B5Shelf takedown 333-2682600001193125-23-155650
2023-05-25424B5Shelf takedown 333-2682600001193125-23-154339
2023-05-16EFFECTDeclared effective 333-2682619999999995-23-001449
2023-05-16EFFECTDeclared effective 333-2682609999999995-23-001448
2023-05-16424B5Shelf takedown 333-2682600001193125-23-146200
2022-11-09S-3Shelf registered 333-2682610001193125-22-280728
2022-11-09S-3Shelf registered 333-2682600001193125-22-280725
2021-07-19424B4Final prospectus 333-2554910001193125-21-218024
2021-07-15EFFECTDeclared effective 333-2554919999999995-21-002781
2021-07-12S-1/AAmendment 333-2554910001193125-21-212364
2021-05-14S-1/AAmendment 333-2554910001193125-21-161996
2021-05-05S-1/AAmendment 333-2554910001193125-21-151721
2021-04-30S-1/AAmendment 333-2554910001193125-21-145429
2021-04-23S-1Registration filed 333-2554910001193125-21-129264
2021-03-19DRSDraft made public 377-044690000950123-21-003678

All filings of this company · CSV